Breast cancer has the greatest epidemiological impact in women. Opioids represent the most prescribed analgesics, both in surgical time and in immediate postoperative period, as well as in chronic pain management as palliative care. We made a systematic review analyzing the litera-ture’s evidence about the safety of opioids in breast cancer treatment, focusing our attention on the link between opioid administration and increased relapses. The research has been conducted using the PubMed database. Preclinical studies, retrospective and prospective clinical studies, review articles and original articles were analyzed. In the literature, there are several preclinical in vitro and in vivo studies, suggesting a possible linkage between opioids administration and progression of cancer disease. Nevertheless, these results are not confirmed by clinical studies. The most recent evidence reassures the safety of opioids during surgical time as analgesic associated with anesthet-ics drugs, during postoperative period for optimal cancer‐related pain management and in chronic use. Currently, there is controversial evidence suggesting a possible impact of opioids on breast cancer progression, but to date, it remains an unresolved issue. Although there is no conclusive evidence, we hope to arouse interest in the scientific community to always ensure the best standards of care for these patients.

Opioids and breast cancer recurrence: a systematic review / Merlino, Lucia; Titi, Luca; Del Prete, Federica; Galli, Cecilia; Mandosi, Chiara; De Marchis, Laura; Della Rocca, Carlo; Piccioni, Maria Grazia. - In: CANCERS. - ISSN 2072-6694. - 13:21(2021). [10.3390/cancers13215499]

Opioids and breast cancer recurrence: a systematic review

Lucia Merlino
Co-primo
;
Luca Titi
Co-primo
;
Federica Del Prete
;
Cecilia Galli;Chiara Mandosi;Laura De Marchis.;Carlo Della Rocca
Penultimo
;
Maria Grazia Piccioni.
Ultimo
2021

Abstract

Breast cancer has the greatest epidemiological impact in women. Opioids represent the most prescribed analgesics, both in surgical time and in immediate postoperative period, as well as in chronic pain management as palliative care. We made a systematic review analyzing the litera-ture’s evidence about the safety of opioids in breast cancer treatment, focusing our attention on the link between opioid administration and increased relapses. The research has been conducted using the PubMed database. Preclinical studies, retrospective and prospective clinical studies, review articles and original articles were analyzed. In the literature, there are several preclinical in vitro and in vivo studies, suggesting a possible linkage between opioids administration and progression of cancer disease. Nevertheless, these results are not confirmed by clinical studies. The most recent evidence reassures the safety of opioids during surgical time as analgesic associated with anesthet-ics drugs, during postoperative period for optimal cancer‐related pain management and in chronic use. Currently, there is controversial evidence suggesting a possible impact of opioids on breast cancer progression, but to date, it remains an unresolved issue. Although there is no conclusive evidence, we hope to arouse interest in the scientific community to always ensure the best standards of care for these patients.
File allegati a questo prodotto
File Dimensione Formato  
Merlino_Opioids and_2021.pdf

accesso aperto

Note: https://www.mdpi.com/2072-6694/13/21/5499
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 849.04 kB
Formato Adobe PDF
849.04 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1646113
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact